The Pharmaceutical Sciences CAG has recently developed an outcomes scorecard. We reached out to find out how it's helping report outcomes.
King’s College London has signed a three-year deal with global biopharmaceutical company UCB.
Researchers lead a pioneering new study to help reduce agitation and aggression.
A state-of-the-art robot is helping patients at Guy’s Hospital get their medicines quicker.
A new study has found that frequently taking aspirin can lead to an increased risk of major bleeding episodes.
Between a third and half of all medicines aren’t taken as directed. Professor John Weinman takes a look at how we got here.
A new centre is launching to help patients better engage with their treatment.
Five teams from across our partnership have been shortlisted in the 2018 Health Service Journal Awards.
Siobhan Gee, explains how taking a mind & body approach to pharmaceutical healthcare can greatly improve patient outcomes.
Taking a low dose of aspirin can reduce the risk of pre-eclampsia, a King’s College London and King’s College Hospital trial has found.
New research has revealed a method of repurposing existing drugs as novel treatments for depression, using laboratory studies of brain cells